A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC
Clinical trial NCT04465734 · WITHDRAWN
Trial details
- NCT number
- NCT04465734
- Sponsor
- Shanghai Henlius Biotech
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2023-10-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.